Express Pharma - Page 414 of 2248 - Express Pharma

FDA mandates rare vision-loss warning across all GLP-1 drugs

BDR Pharma to acquire controlling stake in Acme’s oral solid formulations business from PAG

Policy shifts test pharma’s resilience

Lupin gets EIR from US FDA for Pithampur Unit-2 facility

Dupixent (dupilumab) gets DCGI approval to treat moderate-to-severe atopic dermatitis

Ensure Best Analytical Outcomes for your Pharma R&D or QA/QC Lab!

Pharma Computer Software Assurance 2023 conference held in Mumbai

Dr Reddy’s selects AWS as cloud provider to develop pharma therapies

OCTAVE study reveals vaccine response in patients with impaired immune systems

Transgender inclusion in healthcare: Breaking barriers and creating equitable clinical trials

Cipla recalls six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) due to container defect

Amneal Parkinson’s drug IPX203 needs to compete with novel subcutaneous levodopa delivery systems post FDA CRL: GlobalData

Venus Remedies gets marketing approvals from Oman, Malaysia, Bosnia and Trinidad & Tobago